This study represents the first examination of how pharmaceutical industry representatives involved in marketing view the use of health outcome and pharmacoeconomic information by health care ...

The use of pharmacoeconomic data in hospital formulary decisions was explored. Data were collected from pharmacist members of pharmacy and therapeutics (P&T) committees in 204 Florida hospitals.

and pharmacoeconomic analysis. Joseph’s most recent experience was in leading the oncology medical affairs team for a large Fortune 100 pharmaceutical company in the US. In this capacity ...

Instead, if they could think about the real value of vaccines in preventing diseases and the overall pharmacoeconomic cost-savings, we could have a healthy society. What factors have influenced ...

As Cohen also points out on page 103 of this issue, we need appropriately designed and timely pharmacoeconomic studies to assess both symptomatic end points and total health-care-related costs ...

Dr Krueger has spent eight years conducting pharmacoeconomic and outcomes research, specifically measuring the clinical and economic impact of pharmacy services, modeling disease interventions, and ...

A forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care.

For example, self-funding interventional pharmacoeconomic (IVPE) trials can identify affordable alternatives to high-cost therapies, where the cost savings of payers during the trial exceed its ...

Starting 1 August, the director can be a doctor or a pharmacist exclusively because, as the addendum states, medicine and pharmacy are prerequisites for achieving efficient pharmacoeconomic ...

As part of AmerisourceBergen Consulting Services, Lash Group works to serve manufacturers with reimbursement services, patient advocacy programs, health outcomes and pharmacoeconomic consulting ...

is a partially peer-reviewed forum for the dissemination of clinical, pharmacoeconomic, and regulatory information to payers, health care policy experts, and providers associated with cancer care.